Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.
- Published In:
- Frontiers in oncology, 12, 837952 (2022)
- Authors:
- Li, Li(8), Chen, Xiaoyuan(7), Yu, Jinming, Yuan, Shuanghu
- Database ID:
- RPEP-06300
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06300APA
Li, Li; Chen, Xiaoyuan; Yu, Jinming; Yuan, Shuanghu. (2022). Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.. Frontiers in oncology, 12, 837952. https://doi.org/10.3389/fonc.2022.837952
MLA
Li, Li, et al. "Preliminary Clinical Application of RGD-Containing Peptides as PET Radiotracers for Imaging Tumors.." Frontiers in oncology, 2022. https://doi.org/10.3389/fonc.2022.837952
RethinkPeptides
RethinkPeptides Research Database. "Preliminary Clinical Application of RGD-Containing Peptides ..." RPEP-06300. Retrieved from https://rethinkpeptides.com/research/li-2022-preliminary-clinical-application-of
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.